Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 50,027 | 42,989 | 45,485 | 45,243 | 37,605 |
| Operating Income | -50,027 | -42,989 | -45,485 | -45,243 | -37,605 |
| Other Income | 7,999 | 5,649 | 5,800 | 6,060 | 5,391 |
| Pre-tax Income | -42,028 | -37,340 | -39,685 | -39,183 | -32,214 |
| Net Income Continuous | -42,028 | -37,340 | -25,563 | -39,183 | -32,214 |
| Minority Interests | N/A | -192 | -1,760 | N/A | N/A |
| Net Income | $-42,028 | $-37,148 | $-23,803 | $-39,183 | $-32,214 |
| EPS Basic Total Ops | -0.68 | -0.75 | -0.06 | -0.91 | -0.82 |
| EPS Basic Continuous Ops | -0.76 | -0.87 | -0.58 | -0.92 | -0.81 |
| EPS Diluted Total Ops | -0.68 | -0.75 | -0.06 | -0.91 | -0.82 |
| EPS Diluted Continuous Ops | -0.76 | -0.87 | -0.58 | -0.92 | -0.81 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.86 | -0.54 | N/A | N/A |
| EBITDA(a) | $-49,950 | $-42,913 | $-45,408 | $-45,163 | $-37,524 |